Stopping Diabetes Medication Raises Heart Attack and Stroke Risk

Topic: Health

A new study found that stopping GLP-1 diabetes medication can increase heart attack and stroke risk. Researchers studied over 333,000 US veterans with type 2 diabetes who took the medication for up to three years.

GLP-1 medications like Ozempic and Wegovy are commonly used to treat diabetes and help people lose weight. But a new study suggests that stopping these medications can have serious consequences for heart health.

Researchers at Washington University School of Medicine in St. Louis studied over 333,000 US veterans with type 2 diabetes who took GLP-1 medications for up to three years. They found that interrupting or stopping treatment for as little as six months was associated with a higher risk of major cardiovascular events like heart attack and stroke.

The longer patients stayed off treatment, the greater the increase in risk. After two years without GLP-1 therapy, the risk of heart attack, stroke, and death was up to 22% higher than among people who continued treatment.

The study's lead author, Ziyad Al-Aly, said that many people stop taking GLP-1 medications after a few months due to cost or side effects. But this can have serious consequences for heart health.

'When they stop, it's not just weight that comes back; they experience a resurgence in inflammation, blood pressure, and cholesterol,' Al-Aly explained. 'Our data suggest this metabolic whiplash is detrimental to heart health.'

The study was published in BMJ Medicine and suggests that uninterrupted treatment with GLP-1 medications is crucial for maintaining heart protection.

Why It Matters

This study matters because it highlights the importance of continuous treatment with diabetes medications. Many people in India suffer from diabetes, and this study shows that stopping medication can have serious consequences for heart health.

Key Facts

• Over 333,000 US veterans with type 2 diabetes were studied.
• Stopping GLP-1 medication for as little as six months increased heart attack and stroke risk.
• After two years without treatment, the risk of heart attack, stroke, and death was up to 22% higher.
• The study's lead author is Ziyad Al-Aly from Washington University School of Medicine in St. Louis.
• The study suggests that uninterrupted treatment with GLP-1 medications is crucial for maintaining heart protection.

Key Terms

GLP-1

A type of medication used to treat diabetes and help people lose weight.

Type 2 Diabetes

A condition where the body does not produce enough insulin, leading to high blood sugar levels.

Cardiovascular Events

Events such as heart attack and stroke that affect the heart and blood vessels.

Implications

This study matters because it highlights the importance of continuous treatment with diabetes medications. Many people in India suffer from diabetes, and this study shows that stopping medication can have serious consequences for heart health.